EOM 1352: Fri 7 June 2024, 11:36

Current Edition

Discovery Park: Wed 13 November 2024, 10:35
ramusmedical

Maximising Value in the Rare Disease Sector: Begin with the End in Mind

Interest in the development of medicines to alleviate or cure rare
diseases has increased due to positive actions taken by global
regulatory agencies. Alastair MacDonald, Executive Director, Real
World and Late Phase, INC Research, gives an insight into the
interest in the development of medicines to alleviate or cure, ensuring
that the correct clinical environment is in place and understanding
how to drive adoption of the relevant technologies.

Catalyst: Fri 8 November 2024, 14:16
Biosynth: Wed 13 November 2024, 10:18